Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Double Blind Control Study of Antihypertensive Agents: II. Further Report on the Comparative Effectiveness of Reserpine, Reserpine and Hydralazine, and Three Ganglion Blocking Agents, Chlorisondamine, Mecamylamine, and Pentolinium Tartrate
Double Blind Control Study of Antihypertensive Agents: II. Further Report on the Comparative Effectiveness of Reserpine, Reserpine and Hydralazine, and Three Ganglion Blocking Agents, Chlorisondamine, Mecamylamine, and Pentolinium Tartrate
Contributor(s):
Veterans Administration Cooperative Study Group on Antihypertensive Agents Archives of Internal Medicine
In 1956, Freis and a group of physicians in several Veterans Administration hospitals organized a cooperative study group to evaluate antihypertensive agents under well-controlled conditions. In this second of three articles, they confirmed some of the general findings of the first report, that a regimen of reserpine (a ganglionic-blocking agent) combined with hydralazine (a vasodilator) produced far better results than the use of ganglionic-blocking agents alone.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)